Evaluation of the Immune Colloidal Gold Technique for BP180-NC16A-specific Antibodies in the Quick Diagnosis and Monitoring of Bullous Pemphigoid

Birao Fan,Yuchen Tang,Yuan Chang,Xixue Chen,Ping Tu,Mingyue Wang
DOI: https://doi.org/10.1016/j.jdermsci.2022.12.005
IF: 5.408
2022-01-01
Journal of Dermatological Science
Abstract:Background: Bullous pemphigoid (BP) mostly involves elderly patients. The diagnosis of BP requires special immunological tests, which makes some patients unable to be diagnosed and treated timely.Objective: The accuracy and application value of immune colloidal gold technique (ICGT) in BP were evaluated. The colloidal gold was conjugated with recombinant BP180 NC16A protein and mouse IgG an-tibody. As the test and control lines, the mouse-anti-human IgG and goat-anti-mouse IgG, respectively, were blotted on the nitrocellulose membrane.Methods: 414 serum samples of consecutive patients with suspected BP and 15 samples from healthy do-nors were recruited. The consistency between ICGT and ELISA, and between serum and plasma/whole blood were evaluated. Subgroup analyses were performed in terms of clinical characteristics. We also followed up 65 BP patients' strip results to explore the predictive value of ICGT. Results: Strong agreements between ICGT and ELISA(Kappa = 0.902) and between plasma/whole blood and serum samples (Kappa = 0.980) with good stability were observed. The ICGT achieved sensitivity of 93.9%, and specificity of 97.6%. In subgroup analysis, the sensitivity was significantly higher in older patients (96.3%), and with more typical lesions such as blisters (96.2%) and erosions (92.4%). In follow-up, we also found BP patients who kept ICGT-negative in remission state all got consecutive positive strips 1-3 weeks prior to mild new activity or flare.Conclusion: ICGT shows high potential as a rapid and stable option for the diagnosis and monitoring of BP. Further investigations are needed to re-evaluate this technique in a prospective study with a multicenter design.(c) 2023 Japanese Society for Investigative Dermatology. Published by Elsevier B.V. All rights reserved.
What problem does this paper attempt to address?